alexa Urology in the New Era of Medical Treatments | OMICS International
ISSN: 2168-9857
Medical & Surgical Urology

Like us on:

Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Urology in the New Era of Medical Treatments

Anastasios Athanasopoulos*

Department of Urology, Urodynamic Urology Unit, University of Patras Medical School, Patra, Greece

*Corresponding Author:
Anastasios Athanasopoulos
Urodynamic Urology Unit
Department of Urology, University Hospital of Patras
Panepistimioupoli, Patra 26500, Greece
Tel: (781) 598-2232
E-mail: [email protected]

Received date: March 11, 2014; Accepted date: March 15, 2014; Published date: March 18, 2014

Citation: Athanasopoulos A (2014) Urology in the New Era of Medical Treatments. Med Surg Urol 3:e109. doi: 10.4172/2168-9857.1000e109

Copyright: © 2014 Athanasopoulos A. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Medical & Surgical Urology

Urinary symptoms, due to symptomatic Benign Prostatic Hyperplasia (BPH), are bothersome to the patient and have a negative impact on patients’ quality of life. Storage symptoms are mainly attributable to detrusor over activity, which is thought to occur in patients with Benign Prostatic Obstruction. Medical treatment of LUTS, suggestive of Bladder Outlet Obstruction, is the initial choice and α1-adrenoceptor antagonists remain the most widely used pharmacological agents, aiming at the dynamic component of BPH. Thus, therapeutic advances are directed towards the relief of bladder outflow resistance. On the other hand, anticholinergics represent the first line treatment for detrusor overactivity. Currently, the combined treatment for the treatment of BPH with concomitant detrusor overactivity has been so far everyday clinical practice. Other possible combinations, apart from the established combination of α-blocker plus 5α-reductase, are 5α-reductase inhibitors plus anticholinergic, phytotherapy plus α-blocker, α-blocker plus PDE-5 inhibitors, α-blockers plus antiflamatory drugs, anticholinergics plus β3 agonist, α-blockers plus β3-agonist, etc. It is obvious that we are entering in a new era where we have to adjust and consider using multiple drugs for certain treatments. Pharmacotherapy is improving the armamentarium of urologist.

Nowadays more and more medical therapies are used in urology, especially functional urology. Antimuscarinics, α-blockers, 5α-reductase inhibitors, PDE-5 inhibitors, β3 agonist, desmopresin, duloxetin, melatonin receptor agonist, LHRH agonist, GHRH antagonist are drug classes which are used in the treatment of urological diseases. All these drugs can be used alone or in different combinations for the confront of urological dysfunctions. The use in combination of three or four of these drugs in the near future it is not only a scenario but rather a fact. Over the last 15 years, an increase has been noticed in USA in the use of medications for the treatment of BPH. From 1993 to 2010, the use of BPH medication increased from 14% of visits in 1993- 1995 to over 40% of visits in 2008-2010 [1]. Providers seem to have adopted new treatment strategies and novel medications [1].

As the balance sometimes is in favor of medical treatment in comparison with surgical one, the need for a more appropriate training of new generation urologists is rising. The indications and contraindications of drugs are very critical. Many of our patients are in polypharmacy suggesting that is very important to know the interactions between the different pharmaceutical substances. A balance between the surgical and medical training is necessary in a way that urologist will become familiar with the use of different drugs as with the use of new and classical surgical techniques. Urology with the enrichment and the progress of last twenty years became a specialty with both Surgical and Medical background, wide and profound enough to attract the attention of new talented colleagues who will lead the specialty in new scientific progress.


Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Recommended Conferences

  • 7th International Conference and Exhibition on Surgery June 21-23, 2018 Dublin, Ireland Theme: Advancements and Endeavours in the Field of Surgery
    June 21-23, 2018 Dublin, Ireland Dublin, Ireland
  • World Summit on Trauma and Reconstructive Surgery Sep 10-11, 2018 Singapore Theme: Expanding new horizons in Trauma and Surgery
    Sep 10-11, 2018 Singapore City, Singapore
  • International Conference on Reproduction and Fertility October 18-19, 2018 Abu Dhabi, UAE
    October 18-19, 2018 Abu Dhabi, UAE
  • 11th International Conference on Clinical and Medical Case Reports October 22-23, 2018 Turkey
    October 22-23, 2018 Istanbul, Turkey

Article Usage

  • Total views: 11966
  • [From(publication date):
    June-2014 - Jun 18, 2018]
  • Breakdown by view type
  • HTML page views : 8173
  • PDF downloads : 3793

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals


[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7